Cocrystal pharma, inc. reports earnings results for the third quarter ended september 30, 2019

Cocrystal pharma, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 492,000 compared to usd 0 a year ago. operating loss was usd 1.808 million compared to usd 2.419 million a year ago. net loss was usd 1.780 million compared to usd 1.868 million a year ago. basic loss per share from continuing operations was usd 0.06 compared to usd 0.06 a year ago. for the nine months, total revenue was usd 6.162 million compared to usd 0 a year ago. operating loss was usd 481,000 compared to usd 6.621 million a year ago. net loss was usd 324,000 compared to usd 4.762 million a year ago. basic loss per share from continuing operations was usd 0.01 compared to usd 0.17 a year ago.
COCP Ratings Summary
COCP Quant Ranking